Antares_3Dface

May 17, 2010 - New technologies in ultrasound are designed to improve efficiency and image quality in obstetrics and gynecological (OB/GYN) imaging.

The latest acoustic technologies are able to deliver clearer 2-D, Doppler and 3-D/4-D imaging for many demanding requirements in
maternal-fetal medicine.

At the 58th Annual Clinical Meeting of American Congress of Obstetricians and Gynecologists (ACOG) in San Francisco. Siemens Healthcare will feature some of these advanced clinical applications in OB/GYN imaging with its syngo.fourSight Workplace, a work-in-progress image management software.

The volume imaging software offers a true stereoscopic view of 3-D images. Created in collaboration with NVIDIA Corp., the new technology creates a 3-D imaging experience that is designed to be more immersive, detailed and realistic than previous solutions. NVIDIA 3D Vision stereoscopic glasses and NVIDIA Quadro FX high-end professional graphics solutions render 3-D/4-D images of the fetus.

The clinical images, obtained with the ACUSON S2000 system, are further enhanced using Amnioscopic Rendering, a Siemens technology that uses NVIDIA 3D Vision technology, users can experience 3-D images in real 3-D. This enhancement is intended to provide additional information to the physician and assist in communication between surgeons and patients or aid in treatment or surgical planning.

The ACUSON S2000 system also captures data over multiple heart cycles and creates a 3D fetal heart volume, allowing sonographers to view the fetal heart in multiple planes.

Another highlight of the ACUSON S2000 system – Women’s Imaging as well as the ACUSON X300 system PE – Women’s Imaging includes syngo Auto OB measurements, an advanced clinical tool that automates routine biometry measurements of the fetus.

For more information: www.siemens.com/healthcare


Related Content

News | Ultrasound Imaging

Feb. 25, 2026 — GE HealthCare is introducing the next generation of LOGIQ general imaging ultrasound systems – an ...

Time February 25, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Digital Pathology

Feb. 11, 2026 — Leica Biosystems has announced the global launch of the Leica CM1950 Cryostat with DualEcoTec Cooling ...

Time February 11, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
Subscribe Now